{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Global Medical REIT, Inc.
Global Medical REIT Hits 52-Week Low at $30.09 Amid Profit Declines
Global Medical REIT, Inc. has reached a new 52-week low, reflecting recent volatility despite a strong one-year performance. The company, with a market cap of USD 554 million, faces challenges with declining profits but shows long-term growth potential and robust institutional holdings, indicating confidence in its fundamentals.
Global Medical REIT Forms Golden Cross, Signals Potential Bullish Breakout
Global Medical REIT, Inc. has recently achieved a Golden Cross, indicating a potential shift in market momentum. The stock has demonstrated impressive performance, with a significant one-day increase and a substantial year-over-year surge. Technical indicators suggest a bullish outlook, despite some bearish signals on the RSI.
Global Medical REIT, Inc. Hits New 52-Week High of $39.93
Global Medical REIT, Inc. achieved a new 52-week high of USD 39.93 on September 22, 2025, reflecting a remarkable 317.49% increase over the past year. With a market capitalization of USD 554 million, the company offers a dividend yield of 4.35% and has shown significant upward movement from its previous low of USD 6.06.
Is Global Medical REIT, Inc. technically bullish or bearish?
As of August 11, 2025, Global Medical REIT, Inc. shows a mildly bearish trend with mixed signals from technical indicators, having outperformed the S&P 500 in the short term but significantly underperformed over the past year.
Is Global Medical REIT, Inc. overvalued or undervalued?
As of August 3, 2021, Global Medical REIT, Inc. is considered very attractive due to its undervaluation indicated by a Price to Book Value of 0.89 and an EV to EBITDA ratio of 4.35, despite a higher P/E ratio of 48 compared to peers, and while it has underperformed the S&P 500 over the long term, it recently showed a potential turnaround with a 1-month return of 16.07%.
Is Global Medical REIT, Inc. overvalued or undervalued?
As of August 3, 2021, Global Medical REIT, Inc. is considered undervalued with a valuation grade upgrade to very attractive, despite a high P/E ratio of 48 and underperformance against the S&P 500, indicating potential investment appeal compared to peers like Dynex Capital, Inc.
Is Global Medical REIT, Inc. technically bullish or bearish?
As of May 5, 2025, Global Medical REIT, Inc. exhibits a bearish trend with strong indications from multiple indicators, including bearish MACD and moving averages, despite a mixed momentum signal from the RSI.
Who are in the management team of Global Medical REIT, Inc.?
As of March 2022, the management team of Global Medical REIT, Inc. includes Mr. Jeffrey Busch as Chairman, President, and CEO, with Ms. Huiqi Zhang and Mr. Jingguo Zhang as Directors, and Mr. Henry Cole, Ms. Paula Crowley, and Dr. Matthew Cypher as Independent Directors.
What does Global Medical REIT, Inc. do?
Global Medical REIT, Inc. acquires and leases licensed healthcare facilities to clinical operators. It has a market cap of $451.94 million, with recent net sales of $38 million and a net profit of $4 million.
How big is Global Medical REIT, Inc.?
As of Jun 18, Global Medical REIT, Inc. has a market capitalization of 451.94 million, with net sales of 154.28 million and a net profit of 8.12 million over the last four quarters. The company's total assets are reported at 1,256.49 million, with shareholder's funds of 534.13 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
